The trial is enrolling adult women with recurrent ovarian cancer after at least two previous therapies. Credit: Jo Panuwat D / Shutterstock.com. (Jo Panuwat D / Shutterstock.com.) Anixa Biosciences ...

Tregzi (clinically known as Orca-T) is an allogeneic cellular immunotherapy consisting of purified regulatory and conventional T cells.

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...